UK Court Rejects PMI's Heat-Not-Burn Patent Appeal

Dec.20.2022
UK Court Rejects PMI's Heat-Not-Burn Patent Appeal
PMI's patent application for heating tobacco was rejected by a UK court, a part of a global patent dispute with BAT.

According to sources familiar with the matter, on December 19, a UK appellate court rejected Phillip Morris International's (PMI) application to restore its patent on a method of heating tobacco. This is the latest ruling in the global patent war between PMI and British American Tobacco (BAT).


On Friday, the appeal court upheld the decision of the High Court that PMI's patent was invalid due to obviousness, but noted that the lower court judges should take their time to consider whether one of the patents had been infringed upon.


In a letter to the appellate court, Chief Justice Christopher Floyd stated, "This negligence will have regrettable consequences, and if we allow the appeal, we will have to refer the case back to the judge for further rulings, which will undoubtedly increase costs.


The ruling on Friday marks the latest development in an international dispute between two companies over tobacco heating technology as they strive to gain dominance in the "heat not burn" market, which involves heating tobacco to release nicotine without burning it.


This case was filed by Nicoveventures in April 2020 in an attempt to invalidate four PMI patents that were applied for in 2017. A few months prior, BAT had launched its own heated tobacco product. In response, PMI filed a counterclaim for infringement, which was heard alongside the invalidity suit.


Nicoveventures and BAT argued in the High Court that PMI's patent relies on an invention from 1994 called Deevi.


According to Friday's ruling, this invention describes a "film heater" that can be incorporated into "smoking articles of the same size and shape as traditional cigarettes.


In July 2021, Judge Marcus Smith at the High Court declared four patents of PMI invalid, stating that they were a "non-innovative combination" of heating systems and insulation materials, aimed at reducing equipment heat loss. Judge Smith also found that a skilled team could make modifications, including replacing the "disposable insert" described in Deevi, to create a reusable heater similar to the PMI patent.


The appellate court has ruled to limit the scope of appeal to only consider one out of four patents, as they are all related to the same original patent application.


In its appeal, PMI argued that Judge Smith was mistaken in determining that its patent described a method of heating tobacco using "multiple tracks". The company maintained that the patent's claims only covered a single track, with "multiple portions" connected to the heater's power source.


According to PMI's lawyer, "None of the tracks have individually connectable components, which is not covered.


Lawyers from Nicoveventures and BAT have accused PMI of attempting to disrupt the situation and are requesting that the appellate court overturn this decision, as it does not imply that a re-evaluation is possible during the appeal.


However, the appellate court upheld the original ruling and determined that Judge Smith had not erred in defining the patent claims when considering whether PMI's invention was obviously valid according to Devi's viewpoint.


The appellate court has rejected PMI's appeal. However, the court noted that despite providing "plenty of evidence," Judge Smith failed to determine whether the patent in question was infringed upon by Deevi.


However, the appeal was rejected because the appellate court found that there were no grounds to overturn the decision that the main claims of PMI's patent were valid.


On Monday, PMI representatives declined to comment.


Representatives of BAT did not respond immediately to a request for comment.


PMI and BAT are currently embroiled in a patent dispute over "heat-not-burn" technology throughout Europe. Parallel lawsuits have been initiated in Germany, Italy, Greece, Poland, Bulgaria, and the Czech Republic.


Judges Richard Arnold, Christopher Nugee and Christopher Floyd attended the panel of the Court of Appeals.


PMI was represented by Andrew Lykiardopoulos QC of 8 New Square and Tom Alkin of 11 South Square, with guidance from Powell Gilbert LLP.


Representatives from Nicoventures and BAT are Adrian Speck KC from 8 New Square and Kathryn Pickard from 11 South Square, respectively, guided by Kirkland & Ellis International LLP.


The case PMI v. NICOVNCHEUS is currently being heard in the appellate court under case number CA-2021-000302.


2FIRSTS will continue to report on this topic, stay tuned for more updates.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands has agreed to acquire 100% of Swedish modern oral nicotine company Yoik Group AB for an initial SEK515 million, equivalent to about US$53.9 million, plus a deferred payment linked to performance over the next two years. Yoik owns nicotine pouch brand Helwit, which held about 3.4% of Sweden’s modern oral nicotine market over the past 12 months. Imperial says the acquisition will more than double its existing share of the Swedish market. Helwit is also sold elsewhere in the Nordics, through European online channels and in selected UK retail outlets.
Sep.08
Reuters Tracks Big Tobacco’s Shift Beyond Cigarettes as Nicotine Pouches Vie for the Next Growth Curve
Reuters Tracks Big Tobacco’s Shift Beyond Cigarettes as Nicotine Pouches Vie for the Next Growth Curve
As cigarette markets face long-term pressure, major tobacco companies are increasingly turning to nicotine pouches in search of growth beyond combustible tobacco. Reuters has examined whether nicotine pouches can become the next strategic growth platform for companies including Philip Morris International, British American Tobacco and Japan Tobacco. PMI strengthened its position through the acquisition of Swedish Match and its ZYN brand, while BAT and JTI continue expanding their own nicotine pouch portfolios. The category has gained attention because of its smoke-free, device-free format, but regulation, youth-use concerns and market scale will determine whether it can become a long-term growth engine.
Regulations
Aug.18 by 2Firsts Perspectives
New Zealand Associate Health Minister Casey Costello Warns on Illicit Cigarettes as Legal Tobacco Sales Halve Over Decade
New Zealand Associate Health Minister Casey Costello Warns on Illicit Cigarettes as Legal Tobacco Sales Halve Over Decade
New Zealand Associate Health Minister Casey Costello said legal tobacco sales in the country have fallen by more than half over the past decade, with sales declining more than 20% in 2025 compared with the previous year. She warned that the decline may not fully reflect lower smoking rates, as increased availability of illicit cigarettes could also be contributing. The government said it would continue strengthening tobacco and vape retail enforcement while monitoring the impact of illicit tobacco on public health and tax revenue.
Aug.26
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Philip Morris Japan (PMJ) launched Bold Ruby as a new regular color for the IQOS ILUMA i and IQOS ILUMA i ONE in Japan on September 16, 2026, priced at JPY 6,980 and JPY 3,980, respectively. Initial sales began through IQOS online and physical channels, with convenience stores and selected tobacco retailers set to follow from September 29. Bold Ruby is a regular rather than limited-edition colorway and is available for the ILUMA i and ILUMA i ONE, but not the ILUMA i PRIME. The release does not involve changes to the devices' core hardware or functions.
Sep.22
UK HMRC Issues One-Month Countdown Warning, Urges Vape Businesses to Prepare for New Tax Rules
UK HMRC Issues One-Month Countdown Warning, Urges Vape Businesses to Prepare for New Tax Rules
The UK’s Vaping Products Duty and Vaping Duty Stamps Scheme will take effect on October 1, 2026. All vaping liquids manufactured in or imported into the UK will face a flat excise duty of £2.20 per 10ml, whether or not they contain nicotine. Newly manufactured or imported products released onto the UK market from October 1 will require a valid duty stamp, while eligible existing unstamped inventory can continue to be sold through March 31, 2027. From April 1, 2027, all vaping products outside duty suspension must carry a valid stamp.
Sep.03